Melissa Zegley
Adult Health · Carlisle, PANPI 1518000769
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.8% of the total across 481 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 30 manufacturers reported payments, led by AbbVie at 32.0% of the total. 2025 is the largest year on record at $3,263, 3.7 times the $889 reported in 2021. Among adult health clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 481 payments — averaging $19.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Johnson & Johnson$2K
- Takeda Pharmaceuticals U.S.A., Inc.$947
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$544
- Gilead$387
- Pfizer$354
- plus $2K from 24 others
What the payments were for
- Food & beverage$9,26098%
- Education$2052%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 134 | $3,027 |
| Johnson & Johnson(2 entities) | 128 | $1,962 |
| Takeda Pharmaceuticals U.S.A., Inc. | 46 | $947 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 31 | $544 |
| Gilead | 16 | $387 |
| Pfizer | 18 | $354 |
| Ardelyx, Inc. | 16 | $336 |
| Sanofi | 8 | $213 |
| Ironwood Pharmaceuticals, Inc | 12 | $178 |
| Bristol Myers Squibb | 10 | $173 |
| Ipsen Biopharmaceuticals, Inc | 10 | $153 |
| Merck | 8 | $137 |
| Janssen Scientific Affairs, LLC | 1 | $118 |
| Madrigal Pharmaceuticals | 4 | $115 |
| Regeneron Healthcare Solutions, Inc. | 4 | $108 |
| Lilly USA, LLC | 4 | $91 |
| Phathom Pharmaceuticals, Inc. | 8 | $91 |
| Ferring Pharmaceuticals Inc. | 4 | $74 |
| Celltrion USA Inc. | 3 | $73 |
| E.r. Squibb & Sons, L.L.C. | 1 | $66 |
| Intercept Pharmaceuticals, Inc. | 3 | $63 |
| Exact Sciences | 2 | $52 |
| Daiichi Sankyo Inc. | 2 | $47 |
| Nestle Healthcare Nutrition Inc. | 2 | $29 |
| Amgen | 1 | $28 |
| Alnylam Pharmaceuticals Inc. | 1 | $25 |
| QOL Medical, LLC | 1 | $24 |
| Novo Nordisk | 1 | $19 |
| Fresenius Kabi USA, LLC | 1 | $18 |
| Axonics, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,465 in reported general payments places this provider in the 95th percentile of 899 adult health providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CreonLipase/Protease/Amylase | 16 | $105,280 |
| Omeprazole | 180 | $2,848 |
| Pantoprazole Sodium | 155 | $2,466 |
| Famotidine | 121 | $2,213 |
| Mesalamine | 12 | $1,352 |
| Esomeprazole Magnesium | 30 | $1,288 |
| Colestipol Hcl | 22 | $1,077 |
| Dicyclomine Hcl | 29 | $298 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieCreon | $3,027 | $105,28016 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 899 adult health providers in Pennsylvania.
Other adult health in Carlisle
- Beth SandyPhiladelphia$924K
- Jennifer MondilloSchwenksville$396K
- Diane NewmanPhiladelphia$343K
- Elizabeth FaustDouglassville$342K
- Abigail SmithPhiladelphia$302K
- Jean CainAllentown$214K
- Jennifer KeeleyWexford$97K
- Debra EvansFarrell$85K
- Bethann MallonBlue Bell$65K
- Catherine HoldsworthPhiladelphia$64K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.